Super Bowl Victory ...
Health Care: Drugs
Savient Pharmaceuticals (SVNT: NASDAQ)
$2.30 0.00 | 0.00%
02/08/12 - 02:35 PM ET
391.99K / 1.58M
Vol / Avg. Vol:2.33 / 2.30
Open / Prev. Close:2.28 - 2.33
Today's Range:2.04 - 11.91
52 Wk Range:3.14%
Performance YTD:TheStreet Rating:
Portfolios with SVNT
- Portfolio NameUser Type
- Contributor13 Biotech Stocks Bought an...
- Contributor10 Most Shorted Stocks in B...
- ContributorStocks With Big Insider Buy...
- Contributor4 Small Stocks With Buyout ...
- Usertracking
- Userjoeg148 Portfolio 1
- UserGlobal Marko 1
- UserPART 2 JPMorgan 28th Annual...
- UserHi Yielder
- UserAMC - High Risk
Latest SVNT Headlines from TheStreet
- Savient Stock Gaps Down On Today's Open (SVNT) 02.01.12 | 09:02 am
- Savient Stock Hits New 52-Week Low (SVNT) 12.08.11 | 11:12 am
- Savient Stock Hits New 52-Week Low (SVNT) 11.28.11 | 03:11 pm
- Savient Stock Hits New 52-Week Low (SVNT) 11.14.11 | 12:11 pm
- Savient Stock Hits New 52-Week Low (SVNT) 11.04.11 | 10:11 am
- Savient Stock Hits New 52-Week Low (SVNT) 10.20.11 | 10:10 am
- Savient Stock Hits New 52-Week Low (SVNT) 10.04.11 | 02:10 pm
- 10 Most Shorted Stocks in Biotech 10.04.11 | 09:10 am
- 5 Stocks With Big Insider Buying 09.21.11 | 01:09 pm
- Dendreon's Blowup Spreads Across Biotech 08.04.11 | 10:08 am
Press Releases for SVNT
- Savient Pharmaceuticals And Jim Belushi Launch "Check Out Your Gout" Educational Campaign - PR Newswire 11.07.11 | 08:11 am
- Savient Pharmaceuticals Announces Publication Of Pivotal Phase III KRYSTEXXA® Data In JAMA Demonstrating Significant Benefits In Refractory Chronic Gout Patients - PR Newswire 08.16.11 | 04:08 pm
- Savient Pharmaceuticals To Present At The Wedbush Securities 2011 Life Sciences Management Access Conference - PR Newswire 08.10.11 | 04:08 pm
- Savient Pharmaceuticals To Hold Second Quarter 2011 Financial Results Conference Call On Thursday, August 4, 2011 - PR Newswire 07.20.11 | 04:07 pm
- Savient Pharmaceuticals Submits European Marketing Authorization Application For KRYSTEXXA® - PR Newswire 05.04.11 | 06:05 pm
- Savient Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire 05.02.11 | 08:05 am
- Savient Pharmaceuticals To Present Multiple Abstracts At The European League Against Rheumatism (EULAR) 2011 Annual Congress - PR Newswire 04.28.11 | 04:04 pm
- Savient Pharmaceuticals To Present At The Bank Of America Merrill Lynch 2011 Health Care Conference - PR Newswire 04.27.11 | 04:04 pm
- Savient Pharmaceuticals To Present At The ROTH 23rd Annual OC Growth Stock Conference - PR Newswire 03.08.11 | 04:03 pm
- Savient Pharmaceuticals To Present At The 31st Annual Cowen & Co. Health Care Conference - PR Newswire 03.02.11 | 04:03 pm
Partner Headlines for SVNT
- Company News for February 2, 2012 - Corporate Summary - Zacks 02.02.12 | 10:02 am
- Savient Pharmaceuticals Announces New Data Surrounding KRYSTEXXA - Benzinga 11.05.11 | 02:11 pm
- Company News for November 4, 2011 - Corporate Summary - Zacks 11.04.11 | 10:11 am
- 16 Micro-Cap Stocks Being Targeted By Short Sellers - Seeking Alpha 10.26.11 | 09:10 am
- Savient Pharmaceuticals: Value Play Or Value Trap? - Seeking Alpha 09.22.11 | 09:09 am
- Savient Pharmaceuticals Names Kenneth J. Zuerblis Chief Financial Officer - Benzinga 09.12.11 | 01:09 pm
- Ardea Agrees with FDA on Gout Candidate - Analyst Blog - Zacks 09.09.11 | 04:09 pm
- 5 Biotech Takeover / LBO Targets With Bullish Short Trends - Seeking Alpha 07.15.11 | 07:07 pm
- Are These 10 Sick Healthcare Companies Terminally Ill? - Seeking Alpha 07.07.11 | 09:07 am
- Top 10 Oversold Stocks Experiencing Increasing Short Interest - Seeking Alpha 06.21.11 | 09:06 am
